NEW YORK , Oct. 28 (GenomeWeb News) - Invitrogen will acquire DNA Research Innovations of Kent, UK, for $30 million in cash and $30 million in payments contingent on the completion of research and development milestones, the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.